Anja Bukovac

504 citations
15 papers · 320 indexed · h-index 9
Topics
Wnt/β-catenin signaling in development and cancer (5 papers)Glioma Diagnosis and Treatment (4 papers)Epigenetics and DNA Methylation (4 papers)

In The Last Decade

Anja Bukovac

14 papers receiving 310 citations

Peers

Anja Bukovac
Comparison fields: 5 of 61
  • Molecular Biology 179
  • Oncology 92
  • Cancer Research 89
  • Pathology and Forensic Medicine 63
  • Pulmonary and Respiratory Medicine 52
Replace Nicola Inzerilli with:
Nicola Inzerilli Italy
Natsumi Kawasaki Japan
Kelly E. Craven United States
Gina M. Ney United States
A. Costa Italy
A P Kyritsis United States
Mohammad Ahmad United States
Feda H. Hamdan United States
Hanna Göransson Kultima Sweden
Aicha El Bakkali Spain
Anja Bukovac relative to Nicola Inzerilli Italy Nicola Inzerilli's profile →
Citations per field
00.5×1.5×2.2×
Nicola Inzerilli · 1×
Citations per year

Countries citing papers authored by Anja Bukovac

Since Specialization
Citations

This map shows the geographic impact of Anja Bukovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Bukovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Bukovac more than expected).

Fields of papers citing papers by Anja Bukovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Bukovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Bukovac. The network helps show where Anja Bukovac may publish in the future.

Co-authorship network of co-authors of Anja Bukovac

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Bukovac. A scholar is included among the top collaborators of Anja Bukovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Bukovac. Anja Bukovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 25
3 13
4 2
5 27
6 15
7 2
8 7
9 17
10 165
11 11
12 3
13 17
14 10
15 5

About Anja Bukovac

Anja Bukovac is a scholar working on Ophthalmology, Genetics and Cancer Research, having authored 15 papers that have together received 320 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (5 papers), Glioma Diagnosis and Treatment (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (89 citations), Pathology and Forensic Medicine (63 citations) and Genetics (36 citations). Anja Bukovac has collaborated with scholars based in Croatia, United States and Denmark. Frequent co-authors include Nives Pećina‐Šlaus, Anja Kafka, Iva Salamon, Petar Brlek, Kamelija Žarković, Davor Tomas, Kristina Gotovac, Reno Hrašćan, Goran Mrak and Željka Krsnik. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026